• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Over $10 Million Bet On DiamondHead Holdings? Check Out These 4 Stocks Insiders Are Buying

    1/17/23 9:04:19 AM ET
    $APPN
    $DHHC
    $FATE
    $PLAY
    Computer Software: Prepackaged Software
    Technology
    Consumer Electronics/Appliances
    Industrials
    Get the next $APPN alert in real time by email

    Although US stocks closed higher on Friday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    Appian

    • The Trade: Appian Corporation (NASDAQ:APPN) 10% owner Colin Moran acquired a total of 265,000 shares an average price of $32.96. To acquire these shares, it cost around $8.74 million.
    • What’s Happening: Barclays recently maintained Appian with an Underweight and lowered the price target from $30 to $25.
    • What Appian Does: Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications.

    Fate Therapeutics

    • The Trade: Fate Therapeutics, Inc. (NASDAQ:FATE) Director John Mendlein acquired a total of 124,679 shares at an average price of $5.60. To acquire these shares, it cost around $698.14 thousand.
    • What’s Happening: Fate Therapeutics recently decided to terminate the collaboration and option agreement with Janssen Biotech Inc, a Johnson & Johnson unit, on revised terms and conditions.
    • What Fate Therapeutics Does: Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States.

    Don’t forget to check out our premarket coverage here

    Read This Next: Why This Analyst Doesn't Expect OPEC To Take Any Action In Coming Months

    DiamondHead Holdings

    • The Trade: DiamondHead Holdings Corp. (NASDAQ:DHHC) Co-CEO, Chairman David T Hamamoto bought a total of 1,000,000 shares at an average price of $10.09. To acquire these shares, it cost around $10.09 million.
    • What’s Happening: The company’s stock gained more than 2% over the past six months.
    • What DiamondHead Holdings Does: DiamondHead Holdings Corp is a blank check company.

    Dave & Buster's Entertainment

    • The Trade: Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) SVP, Chief Int'l Dev Ofc Antonio Pineiro bought a total 3,000 shares at an average price of $42.54. The insider spent around $127.63 thousand to buy those shares.
    • What’s Happening: The company, last month, posted upbeat quarterly sales.
    • What Dave & Buster's Entertainment Does: Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports.

     

    Get the next $APPN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APPN
    $DHHC
    $FATE
    $PLAY

    CompanyDatePrice TargetRatingAnalyst
    Dave & Buster's Entertainment Inc.
    $PLAY
    1/16/2026$30.00Hold → Buy
    The Benchmark Company
    Appian Corporation
    $APPN
    1/12/2026$45.00Equal-Weight → Overweight
    Morgan Stanley
    Appian Corporation
    $APPN
    11/7/2025$38.00Neutral
    DA Davidson
    Fate Therapeutics Inc.
    $FATE
    10/31/2025$5.00Neutral → Buy
    H.C. Wainwright
    Fate Therapeutics Inc.
    $FATE
    10/27/2025$7.00Neutral → Outperform
    Wedbush
    Appian Corporation
    $APPN
    8/8/2025$30.00Neutral
    DA Davidson
    Appian Corporation
    $APPN
    1/14/2025Sector Weight
    KeyBanc Capital Markets
    Appian Corporation
    $APPN
    1/6/2025$37.00Sector Perform
    Scotiabank
    More analyst ratings

    $APPN
    $DHHC
    $FATE
    $PLAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Legal Officer Rodriguez Rodolfo Jr bought $14,673 worth of shares (730 units at $20.10), increasing direct ownership by 5% to 14,500 units (SEC Form 4)

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    1/20/26 4:30:17 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Chief Executive Officer Lal Tarun bought $251,916 worth of shares (8,060 units at $31.26) (SEC Form 4)

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    7/24/25 7:55:45 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Director Redmile Group, Llc sold $573,943 worth of shares (341,633 units at $1.68), bought $668,580 worth of shares (397,964 units at $1.68), disposed of $1,822,692 worth of shares (1,084,936 units at $1.68) and acquired $1,822,692 worth of shares (1,084,936 units at $1.68) (SEC Form 4)

    4 - FATE THERAPEUTICS INC (0001434316) (Issuer)

    12/26/24 9:00:15 PM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APPN
    $DHHC
    $FATE
    $PLAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wehner Tony

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    3/27/26 9:43:43 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    SEC Form 4 filed by Lehner Les

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    3/27/26 9:03:09 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    SEC Form 4 filed by Lal Tarun

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    3/27/26 8:27:44 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    $APPN
    $DHHC
    $FATE
    $PLAY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Fate Therapeutics Inc.

    SCHEDULE 13G/A - FATE THERAPEUTICS INC (0001434316) (Subject)

    3/26/26 6:21:12 PM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Dave & Buster's Entertainment Inc.

    SCHEDULE 13G/A - Dave & Buster's Entertainment, Inc. (0001525769) (Subject)

    3/26/26 5:39:19 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Appian Corporation

    SCHEDULE 13G/A - APPIAN CORP (0001441683) (Subject)

    3/26/26 1:49:30 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    $APPN
    $DHHC
    $FATE
    $PLAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Dave & Buster's upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Dave & Buster's from Hold to Buy and set a new price target of $30.00

    1/16/26 8:58:56 AM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Appian upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Appian from Equal-Weight to Overweight and set a new price target of $45.00

    1/12/26 7:37:33 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    DA Davidson resumed coverage on Appian with a new price target

    DA Davidson resumed coverage of Appian with a rating of Neutral and set a new price target of $38.00

    11/7/25 7:56:55 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    $APPN
    $DHHC
    $FATE
    $PLAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dave & Buster's Entertainment, Inc. to Report Fourth Quarter and Fiscal Year End 2025 Financial Results on March 31, 2026

    DALLAS, March 17, 2026 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner, operator, and franchisor of entertainment and dining venues, today announced that it will report financial results for its fourth quarter and fiscal year ended February 3, 2026 after the market closes on Tuesday, March 31, 2026. Management will host a conference call to discuss these results on Tuesday, March 31, 2026, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time). A live and archived webcast of the conference call will be available under the Investor Relations section of the Company's website at ir.daveandbusters.com. Additionally, participan

    3/17/26 4:05:00 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on March 2, 2026, the Company granted restricted stock units (RSUs) representing 50,700 shares of its common stock to three newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees ente

    3/4/26 4:05:00 PM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APPN
    $DHHC
    $FATE
    $PLAY
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Appian Appoints David Link to Board of Directors

    MCLEAN, Va., Jan. 21, 2026 /PRNewswire/ -- Appian (NASDAQ:APPN) a leader in AI-powered process automation, announced the appointment of David Link to the Appian Board of Directors effective January 25, 2026. Appian announces the appointment of David Link to the Appian Board of Directors effective January 25, 2026.Mr. Link is the Co-Founder and CEO of ScienceLogic, a global leader in AI-driven IT operations, unifying service-centric observability with intelligent automation. Throughout his career, he has worked to solve complex operational challenges facing IT organizations by

    1/21/26 9:30:00 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer

    SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE) (the Company), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today announced the appointment of Kamal Adawi, M.S., M.B.A., to the role of Chief Financial Officer (CFO) effective October 20, 2025. Mr. Adawi brings to the Company more than 20 years of financial leadership experience in the life sciences industry, including over 10 years serving as CFO across innovative life science companies, with deep domain expertise in autoimmune diseases, including lupus. "We are excited to wel

    10/14/25 8:00:00 AM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APPN
    $DHHC
    $FATE
    $PLAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Fate Therapeutics Inc.

    SC 13G/A - FATE THERAPEUTICS INC (0001434316) (Subject)

    11/14/24 7:50:18 PM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dave & Buster's Entertainment Inc.

    SC 13G/A - Dave & Buster's Entertainment, Inc. (0001525769) (Subject)

    11/14/24 4:15:21 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Appian Corporation

    SC 13G/A - APPIAN CORP (0001441683) (Subject)

    11/7/24 4:30:55 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    $APPN
    $DHHC
    $FATE
    $PLAY
    Financials

    Live finance-specific insights

    View All

    Dave & Buster's Entertainment, Inc. to Report Fourth Quarter and Fiscal Year End 2025 Financial Results on March 31, 2026

    DALLAS, March 17, 2026 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner, operator, and franchisor of entertainment and dining venues, today announced that it will report financial results for its fourth quarter and fiscal year ended February 3, 2026 after the market closes on Tuesday, March 31, 2026. Management will host a conference call to discuss these results on Tuesday, March 31, 2026, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time). A live and archived webcast of the conference call will be available under the Investor Relations section of the Company's website at ir.daveandbusters.com. Additionally, participan

    3/17/26 4:05:00 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Appian Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter cloud subscriptions revenue increased 18% year-over-year to $117.0 millionFull year cloud subscriptions revenue increased 19% year-over year to $437.4 million MCLEAN, Va., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: Revenue: Cloud subscriptions revenue was $117.0 million, up 18% compared to the fourth quarter of 2024. Total subscriptions revenue, which includes sales of our cloud subscriptions, license subscriptions, and maintenance and support, increased 19% year-over-year to $162.3 million. Professional services revenue was

    2/19/26 7:05:00 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    Appian To Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

    MCLEAN, Va., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, before the U.S. financial markets open on Thursday, February 19, 2026. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this Registration Link. Once registered, participants can join the call, using their phone with a dial in and PIN. The conference call will also be available live via webcast on the Investor Relations page of the Com

    1/29/26 4:05:00 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology